Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine.
Prolactin (PRL) responses to dopamine (DA) blockers and to direct and indirect DA agonists have been studied in 23 healthy women, 17 women with catamenial migraine and 17 with non-catamenial migraine in both their follicular and luteal phases. PRL responses to the DA blockers were greater in the follicular phase of both migraine groups than in controls. The inhibitory effect of nomifensine on PRL secretion was dampened in the follicular phase of both migraine groups. These findings demonstrate an increased PRL reserve in migraine and suggest the existence of a dopaminergic supersensitivity of the lactotrophic postsynaptic DA receptors. The impaired inhibitory effect of nomifensine on PRL secretion hints at a decrease of the presynaptic DA content in tuberoinfundibular DA neurons. In migrainous women 17-beta-oestradiol levels are higher in both ovarian phases, whereas progesterone concentrations and the progesterone to oestradiol ratio are lower than in healthy subjects in the luteal phase. These data suggest the existence of a change in the oestrogen-dependent modulation of pituitary DA receptors.
Murialdo
G
G
Martignoni
E
E
De Maria
A
A
Bonura
M L
ML
Sances
G
G
Bono
G
G
Polleri
A
A
D000328:Adult; D004294:Domperidone / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004958:Estradiol / Q000097:blood / Q000378:metabolism*; D005260:Female; D005498:Follicular Phase; D006801:Humans; D008090:Lisuride / Q000494:pharmacology; D008183:Luteal Phase; D008881:Migraine Disorders / Q000097:blood* / Q000188:drug therapy; D009627:Nomifensine / Q000494:pharmacology; D011374:Progesterone / Q000097:blood / Q000378:metabolism*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D013469:Sulpiride / Q000494:pharmacology
D009627:Nomifensine; D011374:Progesterone; D004958:Estradiol; D004294:Domperidone; D013469:Sulpiride; D011388:Prolactin; D008090:Lisuride; D004298:Dopamine